6 authorised products containing Bupropion hydrochloride, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Mysimba 8 mg/90 mg prolonged-release tablets EU/1/14/988/001-002 |
Naltrexone hydrochloride, Bupropion hydrochloride | Orexigen Therapeutics Ireland Limited | — |
| Zyban 150 mg prolonged release tablets PA1077/017/001 |
Bupropion hydrochloride | GlaxoSmithKline (Ireland) Limited | Marketed |
| Zyban 150 mg prolonged release tablets PPA2306/005/001 |
Bupropion hydrochloride | Originalis B.V. | — |
| Zyban 150 mg prolonged release tablets PPA0465/496/001 |
Bupropion hydrochloride | PCO Manufacturing Ltd. | — |
| Zyban 150 mg prolonged release tablets PPA23080/035/001 |
Bupropion hydrochloride | Merit Pharmaceuticals Limited | — |
| Zyban 150 mg prolonged-release tablets PPA1463/229/001 |
Bupropion hydrochloride | IMED Healthcare Ltd., | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.